Levels of Soluble Fas in Patients With Myocarditis, Heart Failure of Unknown Origin, and in Healthy Volunteers
- 15 March 1998
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 81 (6) , 798-800
- https://doi.org/10.1016/s0002-9149(97)01032-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Serum Levels of Soluble Form of Fas Molecule in Patients with Congestive Heart FailureThe American Journal of Cardiology, 1997
- Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activationBiochemical Journal, 1995
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995
- Detection of polymorphisms within the FAS cDNA gene sequence by GC-clamp denaturing gradient gel eletrophoresisImmunogenetics, 1994
- Fas‐based lymphocyte‐mediated cytotoxicity against syngeneic activated lymphocytes: A regulatory pathway?European Journal of Immunology, 1994
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisCell, 1991
- Monoclonal Antibody-Mediated Tumor Regression by Induction of ApoptosisScience, 1989
- A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.The Journal of Experimental Medicine, 1989